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BUILDING the
RESEARCH ENTERPRISE of 2028
This edition of Jefferson Research offers a tantalizing peek at the array
of work done at Thomas Jefferson University: from how mitochondria
communicate with nearby organelles, to the use of innovative
textiles to reduce a building’s energy consumption; from how “digital
readiness” can improve health equity, to space travel’s effects on the
immune system.
It also serves as a lens on the exciting path that the our university's
research community will pursue over the next five years, guided by
our new strategic plan for the Jefferson Research Enterprise. The
carefully calibrated plan draws on insights from faculty, students and
staff across the institution. It is rooted in the University’s overarching
tripartite objective: Before decade’s end, Jefferson will be recognized
as a national research university distinguished by programmatic
excellence, innovation and multidisciplinary, multi-sector
partnerships. We will be seen as the model for professions-focused
higher education. We will be a distinctive, robust global presence in
research and education.
Our research strategy builds on our nearly 200-year legacy of
pioneering achievements in education, scientific discovery and
technical invention. Excellence, innovation and collaboration are
woven through the four core elements of our strategic plan.
First, we will leverage the programmatic research themes we have
developed over the past decade to create or expand a select number
of centers of research excellence (CRE). Prioritized by their potential
for scientific and social impact, the CREs will address fields ranging
from Smart and Healthy Cities to Life Energetics to Small RNA
Discovery to Fashion and Textile Futures — and will include
continued expansion of research at our NCI-designated Sidney
Kimmel Cancer Center — Jefferson Health, the Vickie & Jack Farber
Institute for Neuroscience, and the Computational Medicine
Center, as well as launch of a Center for Vaccines and Pandemic
Preparedness and an Institute for Global Health Security.
At the same time, we will continue advancing the work of
individual scholars and small teams as they create and apply
knowledge across a broad range of subjects: from investment
banking practices, to the psychological roots of conspiracy theories;
from sustainable architecture to racism in news media; from
dissemination of Africa-based scholarship to the roots of creativity,
and to women as entrepreneurs. (You’ll find examples of this
exciting and impactful research in the pages of this magazine.)
Second, replicating the success of the Jefferson Institute for
Bioprocessing, we will launch a series of education-based initiatives
that have significant research and development components. Those
initiatives will leverage the rich potential — and Jefferson’s existing
strengths — in areas such as Heatlh Cybersecurity, Biocomputation
Human Factors Engineering and Design Thinking.
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Third, we will continue growing our clinical research program
(which now has more than 1,300 active clinical trials), aiming
to increase patient participation by 50 percent. Toward that
goal, we will build programs to address the specific needs of
Jefferson’s communities through targeted trials addressing
clinical challenges such as stroke, cardiac disease and diabetes.
This initiative is just one facet of a cross-cutting commitment
to expand population science research across the University—
especially the kind of work that will enable us to understand and
counter the roots of health disparities.

The new relationships we create with our local communities
will be the cornerstone of the fourth core element of our
research plan: expanded partnerships and collaborations. We
will, for example, launch regional partnerships to access highend technologies; and catalyze national consortia to pursue
targeted, high-impact research challenges. Of course, we will
also expand the research programs undertaken by our seven
Jefferson global centers and Consortia and by investigator-driven
collaborative studies in 23 countries. With our partners, we
will continue to address challenges ranging from maternal and
infant death in India to road traffic injuries in Rwanda; and pursue
collaborations that open new horizons — such as our work with
investigators in Israel on biomedical projects to be undertaken
on the International Space Station, and our robotics and artificial
intelligence research in Japan.
Over the past decade, building on our predecessors’ achievements, we
have fortified the foundation of a truly extraordinary research
enterprise. That foundation includes a world-class faculty, stateof-the-art core facilities and an energetic culture of team science
and interdisciplinary exchange. We have established strong
seed- and bridge-funding mechanisms and garnered steadily
increasing external support: since 2017, our research revenue
from agencies, corporations and foundations has grown by more
than 64 percent. The dynamic expansion of our discovery and
scholarship is reflected in a quadrupling of our publications to
over 4,000 this past year.
In reading this magazine, I think you will see why we are so
proud of what we have accomplished, and so enthusiastic about
the future of Jefferson’s research enterprise. I firmly believe it
will be a future of both profound discovery and truly beneficial
impact for our community and our world. 

Mark L. Tykocinski, MD
Executive Vice President, Academic Affairs
Provost, Thomas Jefferson University
Anthony F. and Gertrude M. DePalma Dean
Sidney Kimmel Medical College

Programmatic Research

“Programmatic, basic and translational studies are the bedrock of scientific research at Jefferson, and
we are continuing to build on our areas of great strength. These include nationally recognized
programs in cancer mechanisms and immunotherapies, neurodevelopment and neurodegeneration,
infectious diseases and vaccines, fibrotic disease and RNA biology. We will launch other initiatives in
highly promising areas as well — and, working across disciplines and disease areas, we are committed
to having real impact in reducing disparities in care and addressing the nonbiological causes of
disease. To empower our investigators, we will continue making major investments in new research
technologies — capitalizing, for example, on recent acquisitions of flow cytometry and cryo-EM
systems, expanding our bioinformatics infrastructure, and making large-scale additions to the
laboratories and core facilities available to our investigators.” 
Steven B. McMahon, Ph.D.
Senior Associate Provost for Programmatic Science

Clinical Research
“Clinical research brings the leading edge of our knowledge and scientific creativity directly to patients
to improve medical care. Over the next five years, we will continue to empower our physicians and
other investigators to advance new and better ways to promote health and detect, diagnose and treat
disease. To that end, we will encourage substantially more faculty to engage in clinical research, in
several ways: first, by expanding the successful “Clinical Research Boot Camp” for new clinicianscientists; second, by offering more Emerging Medical Science awards, which provide protected time
for early career investigators; third, by increasing internal funding for pilot projects that translate
faculty research into real interventions. We will also build infrastructure, such as the Jefferson Health
Informatics Core, to help investigators organize and analyze electronic health records in ways that yield
population-level insights and point the way to community-focused clinical research initiatives.” 
David Whellan, MD, MHS
Senior Associate Provost for Clinical Research
James C. Wilson Professor of Medicine

Applied Research
“At Jefferson, the term ‘applied research’ has broad application. It ranges from studies of soft materials
and surface imaging to antitrust laws’ effect on foreign investment. It includes academic-corporate
partnerships where our industrial designers investigate and develop solutions for real people’s
challenges, and multidisciplinary projects with concrete impact—such as our initiative that bridges
political science, economics, management, and materials science to help develop a sustainable and
profitable hemp-based industry.
"In the next few years, we will expand our core capacities to do intellectually rigorous, impactful
applied research by providing more bridge and project-completion grants to faculty, expanding
dedicated research space on our East Falls campus, and increasing funding for graduate research and
technical staff. With those resources, we will grow an array of already strong programs in areas such
as business structure and supply chain modeling, product design and development, sustainability and
building systems, and textile and materials technology.” 
Ronald Kander, PhD
Associate Provost for Applied Research

Jefferson.edu/Research
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Reaching
Across the Globe
and to the Stars
From maternal health to science in space, Jefferson’s
global initiatives are attacking pressing problems through
connected learning and investigation.
BY EDYTA ZIELINSKA (ESZ)

Research blooms in an interconnected world. Research that is open to the rich
knowledge, experience and culture of collaborators across the globe is stronger
for it. Thomas Jefferson University is building international partnerships to
tackle health disparities and innovations in medicine, and to broaden access and
opportunities that have lasting impact. Read about Jefferson’s global footprint.
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Africa Coalition

Ireland Center

Israel Center

The Jefferson Consortium of African
Partnerships (JCAP) forms multiinstitutional partnerships with African
colleagues in academia, industry and
government in pursuit of a healthier,
equitable, resilient African future. Led by
Chris Harnish and Lauri Romanzi, MD,
JCAP includes collaborations with faculty
and students across the continent, with
in-depth institutional-level partnerships
in Rwanda and Malawi. In Rwanda, JCAP
is working on initiatives to improve road
traffic and reduce crashes and injuries.
Elizabeth Krebs, MD, has supported
Rwandan institutions to win road-safety
funding from the United Nations Road
Safety Fund and Global Road Safety Facility
of the World Bank. Chris Harnish leads the
Malawi Health and Design Collaborative
in partnership with the two largest tertiary
teaching and research hospitals in the
country. They have developed safer care
models for infectious disease units and are
currently working on designs for the first
regional teaching hospital in the country.

The University has formed a working
partnership with University College
Dublin (UCD), Technological University
Dublin and Ulster University in Northern
Ireland to focus on global issues where
interdepartmental infrastructure already
exists, and where faculty have globally
recognized expertise. The eight content
areas for exploration include architecture
and the built environment, autism spectrum
disorders, maternal child health, eye
diseases health disparities, nutritional
sciences, digital health and technology
applications. Each of the European partner
institutions has a history of having received
HORIZON funding for collaborative
research, as well as ERASMUS funding to
promote student exchanges. The Jefferson
Institute for Bioprocessing (JIB) was
developed by a model created in Ireland.
A joint collaboration with the College of
Architecture and the Built Environment
(CABE) is being explored to expand SMART
Labs, a doctoral program developed at UCD
which grants PhDs credits for practical
life experience. An expanded academic
partnership, which includes Wills Eye
Hospital links new innovation to address
the leading causes of blindness globally.

Led by Zvi Grunwald, MD, at Jefferson,
the Israel Center focuses on collaborations
with innovation and life-science industries
as well as leading academic and medical
centers in Israel. One set of collaborations
is poised to send Jefferson research to the
International Space Station (ISS) aboard
the Rakia mission, the first private mission
to the ISS. Three projects will examine
the impact of space on the human body,
specifically: the effects of missioninduced stress; changes in the urinary
microbiome; and how space travel affects
the immune system.

India Centers
The biggest contributors of maternal
and infant death worldwide are blood
loss during childbirth, hypertension
during pregnancy and preterm birth.
In a landmark clinical trial, India Center
director Richard Derman, MD, and his
research colleagues in the U.S. and India,
along with members of the NIH-funded
Global Network for Women’s and Children’s
Health, showed that daily low-dose aspirin
could safely decrease the risk of preterm
birth by 11%. The trial included nearly
12 thousand women in India, Pakistan,
Guatemala, Democratic Republic of the
Congo, Kenya and Zambia. His prior work
also showed that misoprostol, a common
and inexpensive lipid hormone, could
reduce blood loss during childbirth. Now
Dr. Derman and his global collaborators are
attacking anemia in the RAPIDIRON trial;
anemia affects 50% of pregnant women in
India and is a strong contributor to both
maternal death and neurodevelopmental
outcomes in the children of affected women.

Italy Center
The Italy Center, led by Ignazio R.
Marino, MD, is the first to offer a joint
and unprecedented program granting
students a double MD degree valid
both in the U.S. and Europe, as well as a
Master in Population Health. The Center
is also home to a unique MS program in
fashion design management that draws
from collaborations with major Italian
universities and companies. Italy Center
programs draw international funding
and foster collaboration across borders,
including joint clinical trials on vascular
surgery and stroke/Parkinson’s, and a
partnership aimed at building a new
Institute of Neuroscience in Rome.

Japan Center
The Japan Center, led by Charles Pohl,
MD, has been forging collaborations with
several institutions in Japan in the realms
of education, research and clinical care
innovations. One partnership explores
pandemic-related challenges and new
opportunities in undergraduate nursing
education between Japan and the U.S.
Researchers at Jefferson and in Japan are
evaluating opportunities for synergistic
collaboration in various academic
disciplines, including aging, rehabilitation
medicine technology, telemedicine
applications, robotics and artificial
intelligence. Jefferson is also working
with Toyota and Canon to advance new
educational initiatives for students in
design thinking, innovation and population
health. Finally, the Center is proud to be
hosting researchers from Japan, who are
currently at Jefferson working with expert
PIs in the fields of ischemia/reperfusion
injury, resuscitation science and artificial
intelligence/learning.

Latin America Consortium
Projects in the planning phase include the
creation of collaborative faculty development initiatives with Universidad de Los
Andes in Bogota, Colombia. Ongoing
projects include a new medical student
case-based learning initiative currently
being tested with Universidad CES in
Medellin, Colombia. There are additional
longitudinal clinical research initiatives in
the area of infectious disease with partners
in Peru.

Jefferson.edu/Research

7

4

et al.: Thomas Jefferson University Research - 2022

Bursts of Power

derived from data that includes just five
percent or fewer Black individuals.

Mitochondria fire oxidants to communicate with organelles nearby,
a communication that could be important in various diseases.

Dr. Barta and team found that a commonly
used risk prediction model—the Prostate,
Lung, Colorectal and Ovarian Cancer
Screening Trial modified logistic
regression—does not identify many
high-risk Black patients who could gain
life-saving benefit from early screening.

BY EDYTA ZIELINSKA | ILLUSTRATION BY THOM GRAVES

For a few years now, researchers have
noticed that clusters of mitochondria
abruptly change their activity inside
the cell: a smattering firework here, a
few there, all seemingly random. When
at rest, only a few light up. But when
the cell is stressed, it’s like a meadow
full of fireflies at dusk. What do these
fireworks mean for the cells? Gyorgy
Hajnoczky, MD, PhD, the Raphael Rubin,
MD, Professor of Pathology, Anatomy
and Cell Biology, and his team at the
Jefferson MitoCare Center developed a
toolkit of ultra-resolution instruments
and fluorescent tags to find out what
was happening at the individualmitochondrion level, and discovered
a mechanism for messages whispered
only to the closest of neighbors. While
oxidation drives energy production, it
may also be involved in a new and highly
specific kind of communication.
In recent years, researchers from fields
as far flung as neurology, genetics and
ophthalmology have found a role for

mitochondria in disease. More than
3500 papers, including work from Dr.
Hajnoczky, have linked mitochondria
to Alzheimer’s disease alone, and
the organelle likely plays a role in
nearly every other neurodegenerative
disease. Although many researchers
agree the mitochondria are involved,
they don’t yet know exactly how.
A recent study published by Dave Booth,
PhD, Dr. Hajnoczky and collaborators
in the high-impact journal Molecular
Cell, uncovered a means of specific
communication that could explain how
mitochondria is involved in disease. The
researchers show that mitochondria send
messages to neighboring organelles,
usually the endoplasmic reticulum —
the site of protein and phospholipid
production and calcium storage in the
cell — and the organelles answer back.
Mitochondria discharge oxidants that
trigger the endoplasmic reticulum to
release calcium. Rather than broadcast
to the entire cell, however, these missives

are only meant for organelles in closest
proximity. The rest stay in the dark. But
when the cell becomes stressed, the
mitochondria amplify the whisper into a
full-scale broadcast meant for the entire cell.
What is the use of the messaging for
the mitochondrion and for the cell?
Mitochondria are clearly initiating a
conversation, and the Hajnoczky lab
is working to find out whether these
signals help to maintain the local status
quo and whether the amplification and
expansion of the signals could be involved
in diseases like neurodegeneration. 

Mitochondrial Whispers and Shouts
A single mitochondrion flickers on with an
oxidative burst (bottom left). It sends a signal
to its closest neighbor — the endoplasmic
reticulum, which answers back, without
alerting other organelles. But under stress
(right), as in disease states, these same
oxidative messages are amplified and
broadcast to the entire cell in a global alert.

mitochondria

endoplasmic reticulum
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ILLUSTRATIONS BY JOANA C. CARVALHO

Antitrust Laws
Don't Hinder
Foreign Investment
BY K
 ARUNA MEDA (KM) AND
MERRILL MEADOW (MM)
Foreign investment capital is key to building
robust economies in developing countries.
Many factors influence a nation’s ability to
attract such investment, ranging from political
transparency and bureaucratic efficiency
to inflation and taxation. “Most of those
factors have been studied extensively,” says
Raju Parakkal, PhD, associate professor of
International Relations. “But little research
has explored the effect of pro-competition
laws on foreign investment in emerging
economies, despite their widespread adoption.”
Dr. Parakkal, who studies the interactions
of policy, politics and economy, believed
it was urgent to begin filling that
research gap. Therefore, he undertook a
comprehensive analysis of the effect of
national competition laws on 155 emerging
economies. Using data on the period from
1970 to 2019 from the World Bank’s World
Development Indicators, he considered
the question of whether anti-trust laws
encourage or diminish foreign investment
in developing and transition countries.
His findings strongly suggest that foreign
investment is associated with countries
that employ pro-competition laws,
even after controlling for other possible
determinants of these capital flows. “There
is overwhelming evidence that competition
laws promote foreign investment in these
emerging economies,” says Dr. Parakkal. “Our

analysis demonstrates that multinational
corporations, while being apprehensive
of the possible misuse of competition
laws, generally see long-term positive
effects of these laws on their investments
in emerging economies. Moreover, these
businesses expect the administration and
enforcement of national competition laws
in new jurisdictions to ultimately pivot
to a more pro-market disposition — if
they were not so from the beginning.”
Dr. Parakkal hopes that his study’s finding
will inform policymakers in developing and
transition countries about the importance
of competition laws in encouraging foreign
investment in their economies. And he
advocates for research into other littleexamined factors that could have significant

effect on foreign direct investment. 

The finding emerged from the team’s crosssectional, retrospective study of 1,276 Black
and white patients enrolled in the Jefferson
Lung Cancer Screening Program. It found
that white patients with screen-detected
lung cancer generally had high lung cancer
risk scores; and, theoretically, there should
have been a similar finding among Black
patients. However, the researchers found
that despite having a definitive lung cancer
diagnosis, Black patients were actually
defined by the model as lower risk.
“The study leads us to suggest multiple
changes in the present approach,” Dr. Barta
says. “For example, criteria for lung cancer
screening should be expanded to include
more diverse populations; and risk-calculation
models should include factors such as
environmental contributors, access to health
care, and other social determinants of health.”
“Our research is an important step toward
reducing disparities in screening and early
detection of lung cancer,” she observes. 
KM, MM

Cancer Prediction
Model Misses HighRisk Black Patients
Black men are more likely to die from lung
cancer than persons of any other racial or
ethnic group. A new study suggests that
better detection could reduce that disparity.
“Black individuals develop lung cancer at
younger ages and with less intense smoking
histories compared to white individuals,”
says the study’s leader, Julie Barta, MD,
assistant professor in the division of
Pulmonary and Critical Care Medicine.
Patients referred for lung cancer screenings
are otherwise healthy, but identified by
their doctors as being at high risk via
algorithm-based risk prediction models

Jefferson.edu/Research
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Learning from Drowsy Flies
Who knew that fruit flies slept—or that humans might
benefit from studying their sleep? Kyunghee Koh, PhD,
does. The associate professor of Neuroscience uses fruit flies
(Drosophila melanogaster) to identify the cellular and molecular
mechanisms underpinning sleep. Two of her lab’s recent
studies offer results that are both interesting and potentially
far-reaching.
The first study explored a phenomenon most humans
experience: being lulled to sleep by motion or vibration.
“Babies like to be rocked to sleep, but the neural mechanisms
underlying this phenomenon remain largely a mystery,” Dr. Koh
explains. “We used the fruit fly to study the mechanisms of
sleep induction via vibration.”
The researchers found that flies sleep longer during vibration;
are less responsive to light pulses that would otherwise wake
them; and are better able to function well with less sleep
afterward. They also discovered that the amount of extra sleep
during vibration depends on flies’ genetic background.
The second study explored sleep-related decision making.
“The fly brain is constantly doing a sophisticated costbenefit analysis of what behaviors to pursue in particular
circumstances,” Dr. Koh says. In the latest of a series of studies
on decision making, the researchers looked at how the need
for food would affect fruit flies’ choice of whether to sleep or
mate. Male flies that were deprived of an important source of
protein chose sleep; their well-nourished counterparts chose
to mate.
“It turns out protein is necessary for flies’ offspring to survive,”
explains Dr. Koh. “So, these malnourished males decided
that even a successful mating was less likely to produce live
offspring, and chose sleep over courtship.” The findings of this
study offer new paths for the Koh lab’s continuing exploration
of the molecular basis of behavior.  KM, MM
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A student team guided by Dr. Ku designed a building envelope,
in collaboration with academic partners in China for the Solar
Decathlon 2021 Design Challenge. Details of the adaptive
structure are shown below.

Enveloping Buildings
in Textiles
There are myriad elements that determine how well a building
functions. One of the most important and complex is the design
and composition of its envelope. Similar to the human skin,
the building envelope is the boundary between interior and
exterior, and it has multiple functions: protecting the indoor
environment, facilitating climate control and reducing the
building’s energy consumption.
Kihong Ku, DDES, associate professor of Architecture, broadly
focuses on how technology empowers designers to enhance
design capabilities. Currently, he’s working to improve
building envelopes through innovative application of textile
materials, using advanced computational design and fabrication
technologies.
“Building envelopes have come a long way from when stone
and brick were used for both a building’s structure and its skin,”
Dr. Ku explains. “Today, we are developing envelopes made of
textiles—such as fiber-reinforced composites and fabric- or
foil-membranes—that enable the expression of lightness and
controlled transparency and that meet growing requirements
for ‘intelligence’ and sustainability.”

Inflatable and Deflatable
ETFE Over Green Walls
INFLATABLE & DEFLATABLE ETFE
OVER GREEN WALLS

Perovskite Solar Cell and
Glass Roof/Facade
PEROVSKITE SOLAR CELL AND
GLASS ROOF/FACADE

Operable Solarium
OPERABLE SOLARIUM

Dr. Ku is investigating how to take full
advantage of emerging innovations in textiles
and fibers. For example, he is developing
reconfigurable mold systems that enable costeffective production of complex-shaped fiberreinforced composite panels for building
envelopes. He is also working on adaptive
building envelope systems that use embedded
sensors and actuators to adjust shading
and ventilation mechanisms in response to
changing temperature, sunlight and weather
conditions.
“My projects take advantage of cuttingedge computational design and fabrication
technologies,” Dr. Ku says, “but, frequently,
they also depend on interdisciplinary
collaborations with colleagues and students
in textile design and textile engineering.
These partnerships have been very fruitful:
We have developed new forms or techniques
for making things; but more than that,
we have learned to bridge our disciplines’
fundamental thought processes, creating new
approaches that integrate those distinct ways
of thinking.”  KM, MM

Jefferson.edu/Research
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BY THE NUMBERS

Intellectual Disability a High
Risk for COVID-19 Death
Early in the COVID-19 pandemic,
researchers realized that people over
65 were more likely — 80 times more
likely — to die from a COVID-19 infection
than younger patients. As the pandemic
continued, other risk factors emerged:
underlying health conditions and
those from racial and ethnic minority
groups. Mary Stephens, MD, Wendy Ross,
MD, and colleagues were interested in
whether having an intellectual disability
might be a risk factor also. To find
out, they analyzed a massive dataset
of nearly 65 million patients infected
with COVID-19, in a study published
in NEJM Catalyst. Their analysis showed
that having an intellectual disability put
people at the highest risk for COVID-19
infection and second-highest risk for
death from the disease, after older
adults. As a result of the study, patients
with intellectual disabilities were
prioritized for vaccination.  ESZ

The Secret Sauce in
COVID-19 Vaccines
The first two COVID-19 vaccines in the
U.S. were a unique formulation: mRNA
strands packed inside of a nano-sized
layer of fat — a lipid nanoparticle. The
mRNA held instructions for making
the COVID-19 spike protein, and the
nanoparticles offered a convenient way
to fuse easily with the lipid covering
of our own cells. However, because the
vaccine wasn’t expected to cause all of
the inflammatory side effects — like fever,
chills and body aches — that it did, Botond
Igyártó, PhD, and team wondered whether
the lipid particles might be to blame. To
find out, they injected mice with the lipid
nanoparticles alone (no mRNA), and saw
massive inflammatory reactions. Their
work showed that the nanoparticles were
not just for mRNA delivery, but also could
have been responsible for jump-starting
the immune response, and giving some
of us those achy post-vaccine symptoms.
 ESZ

Design Solutions for
COVID-19 Problems
Jefferson’s focus on design thinking
and innovation paid dividends during
COVID-19, when hospitals, including
our own, were hit with shortages in
everything from hospital gowns and
full-body protective coverings, to masks
and childcare for essential workers.

At Home with Dementia
during the Pandemic
Isolation, due to COVID-19, became
a necessity in the past two years,
especially for those 65 and older due to
their high mortality risk. But limiting
social interaction presents challenges
for maintaining mental wellbeing. It

is particularly problematic for persons
with dementia, as social engagement is
often used to slow the progression of
dementia. Together with colleagues, Kristin
Rising, MD, and Angela Gerolamo, PhD,
interviewed patients with dementia and
their at-home caregivers about the most
challenging aspects of the COVID-19
pandemic. Respondents described how
prolonged isolation led to feelings of
loneliness, depression and worsening
memory problems. Caregivers felt a
heightened responsibility and burden for
care, and reported often putting their own
needs on hold. The work highlights the
need for healthcare providers to develop
and provide interventions and tools to
support families who care for people with
dementia.  ESZ
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Predicting the Severe Cases
of COVID-19
One of the most unsettling facts of
COVID-19 is how difficult it is to predict
when the disease will turn deadly. For
some, there are only mild symptoms; for
others the disease can turn severe in a
rapid and unexpected manner. Colleagues
from the Department of Medicine and
Department of Surgery built a tool to
help clinicians predict those severe cases
that would require closer monitoring.
Using machine learning and clinical
experience, the investigators defined
a list of eight predictors that included
risk factors such as age, sex, diabetes or
labored breathing, together with clinical
measurements collected by blood test.
They used these input variables to create a
web-based tool that could be accessed at
the bedside on a phone or tablet.  ESZ

$1.7

full- and
part-time
paid faculty

WITH

COVID Briefs

Collaborating across disciplines, doctors
and designers, textile experts and frontline
workers came together to come up with
solutions that could relieve the stress
put on the system. When there weren’t
enough ventilators for the patients who
needed them, they developed prototypes
for a computer-controlled ventilator
splitter. When surgical gowns became
more expensive to use, textile researchers
designed a better-fitting surgical gown
that simplified manufacture. When a
factory-issued part of the full-body PAPR
hazard suits kept breaking, a large team
came up with a 3-D printed alternative to
keep the suits in circulation.  ESZ
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the PA Department
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38 applied research
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with 18 funded (47%
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F

or Dr. McCoy-Deh—an educator, researcher,
university administrator and author — her personal inflection point arrived during her time as
a Fulbright Scholar at the University of Ghana’s Kwame
Nkrumah Institute of African Studies (IAS) in 2019-20. She
had chosen that institution for both personal and professional reasons: her husband was raised in Ghana, and they
were eager for their daughter to have a deep experience of
the country and culture. The Nkrumah Institute’s faculty is
widely respected, including accomplished educators and
researchers from across Africa and around the world.
There, she collaborated with faculty to bring relevant
material from U.S. history into courses on the slave trade,
Pan-Africanism and the African diaspora. She soon found
that many assigned readings in courses addressing slavery
and colonization in Africa were authored by non-African
scholars. It was a telling sign of how knowledge is defined
and distributed in the field of African Studies.
“While new perspectives are slowly working their
way into textbooks and curriculum, the main body of
scholarship about Africa is still rooted in Euro-centric
interpretation of events,” Dr. McCoy-Deh explains. “Too
often, those materials included skewed interpretations,
contained omissions or were dominated by European and
colonial perspectives.”

Marcella McCoy-Deh, PhD

Inflecting the Narrative
on African Studies
Inflection points can be powerful events. They can
prompt an individual to take on a new career challenge.
And on occasion, that individual’s decision can redound
to the benefit of thousands of others. Such may be the
case for Marcella McCoy-Deh, PhD, associate professor
of American Studies and director of the Philadelphia
University Honors Institute.
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She had long known about the need to “decolonize”
African Studies, but had not understood the depth of the
problem—nor its broader effects on African scholars. That
realization spurred her to consider—more directly and
intently than she had before—how to transform the way
scholarship about African culture and history is assessed
and presented in global academic literature. Discussions
with colleagues such as University of Ghana historian and
IAS Research Fellow Dr. Edem Adotey made clear that
progress depended on African researchers and educators
being able to overcome a fundamental challenge: having
their intellectual contributions actually acknowledged,
then objectively assessed and validated. “Too often, nonAfrican scholars simply reject or ignore information and
ideas that challenge long-held, Euro-centric views,” Dr.
McCoy-Deh observes.
But there is also a very practical challenge. “While African
scholars are conducting high-quality research, too little
of their work makes it to broadly accessible journals

and textbooks,” she adds. And even when their studies
are published in journals at African universities, those
publications are frequently not accessible on international
databases such as JSTOR and Google Scholar.
As a result, a substantial portion of scholarship
produced by African researchers is difficult to access,
and a generation of comparative scholarship by African
researchers is effectively lost to researchers outside of the
country or region of origin.
Dr. McCoy-Deh thought deeply about ways to help bridge
the access gap, and tested her ideas with colleagues at
the Nkrumah Institute. Their discussions gave rise to a
collaborative initiative called Africa in First Person. It
will be a searchable online repository of work by African
scholars writing on the African experience, providing
abstracts of unpublished articles and links to published
papers. Initially, the repository will invite submissions
of material addressing Western academic dominion in
African scholarship, as well as articles rejected by scholarly
journals for lack of deference to Western ideas.
“Our primary goal is that the repository becomes a widely
accessible information resource for editors, researchers and
students—in Africa and around the world,” Dr. McCoy-Deh
says. “Longer term, we hope that Africa in First Person
will become a bridge creating new collaborations among
researchers and connecting scholars with publishing
organizations.” A key step in the process is developing the
financial support needed to launch the project, and she is
currently working to identify potential funders.
As planning for the initiative evolved, Dr. McCoy-Deh
realized that her commitment to supporting the work
of African scholars had also evolved into a personal and
professional inflection point. “Before I went to Ghana, I
was uncertain what the next phase of my career would
hold. Continue in academic administration? Dive more
deeply into my research or writing?” she says. “But I
have become passionate about this project, and I am
deeply committed to addressing the challenges faced by
African scholars.”
The broader impact of that commitment could well
empower researchers and educators at academic institutions
across the continent and help remake the way Africa is
studied and taught for generations to come.  KM, MM

Jefferson.edu/Research

15

8

et al.: Thomas Jefferson University Research - 2022

Manuela Tripepi, PhD

A Journey of Adaptation

C

onsider Haloferax volcanii, a single
celled organism that thrives in
extreme conditions such as the
very salty Dead Sea. Scientists study it
for clues about potential life on Mars and
about how organisms may adapt to Earth’s
changing climate. Much like the organism
she studies, H. volcanii researcher Manuela
Tripepi, PhD, is an expert at adapting to
challenging situations.
Dr. Tripepi, assistant professor of Biology,
was raised in southern Italy, and following
in the footsteps of her father, was drawn to
the world of biology. She pursued a PhD in
plant biology at the University of Calabria,
focusing on how plants respond to stressful
environments. But even as she was
completing that doctorate, she began to
carve out another scientific path. Her thesis
work on the salt tolerance of olive plants
led her to seek out a researcher on the
other side of the world at the University of
Pennsylvania — Mecky Pohlschröder, PhD,
a widely respected investigator of microorganisms called haloarchaea, of which
H. volcanii is an example. Dr. Pohlschröder
was deeply impressed by their initial
conversation and saw a lot of herself
in this young, immigrant researcher.
A continuing dialogue ensued, with
Dr. Tripepi bringing a plant biologist’s
perspective to the world of microbiology
and spurring a flow of interesting research
questions. Dr. Tripepi was invited
to work on a summer project in the
Pohlschröder lab. Ultimately, she stayed
on, simultaneously completing her PhD
work on olive plants and foraying into the
world of haloarchaea.
The intellectual excitement of that work
prompted her to make the audacious
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decision to pursue a second PhD, in
microbiology, which she received from
the University of Pennsylvania in 2013.
Through that thesis work, Dr. Tripepi was
the first to show that— contrary to current
dogma — H. volcanii is motile and able to
move in response to environmental stimuli
like light or food. “This work opened up
new avenues of research,” observes Dr.
Pohlschröder. “In fact, I have students
in the lab still building on Manuela’s
foundational work, to understand how
motility adds to the adaptation strategies
of H. volcanii.”
Dr. Tripepi joined Jefferson in late 2019
to continue her research on H. volcanii,
focusing on the effects of sub-optimal
temperatures and ultraviolet light on the
organism’s motility. Just as she was setting
up her lab, however, the pandemic hit,
forcing her to hit pause. But alongside her
bench research, she also does pedagogyfocused research and curriculum
development through her role as course
director for undergraduate microbiology.
For example, she creates laboratory
activities that give students first-hand
experience with original research projects.
She developed a COVID-friendly protocol
to monitor wildlife on Jefferson’s verdant
East Falls’ campus — using remotely
operated trail cameras placed in different
locations, students collected data on
patterns in wildlife behavior, including
how the pandemic-caused variance in
human activity affected the animals’
presence. The rich body of studentdeveloped data has been the basis for
poster sessions, thesis projects and a
new grant-funded expansion of the
project to observe birds with smart bird
feeders. Dr. Tripepi has also published

a description of the protocol so that
other institutions can provide a similar
undergraduate research opportunity.
Dr. Tripepi’s scientific and academic
journey of adaptation has been mirrored
in her personal life. Her move to the U.S.
from Italy was fueled, in part, by her
search for acceptance as a member of the
LGBTQ+ community. “Coming to the
U.S. gave me greater freedom to live my
life authentically,” she recalls. “I worried
less about what people around me would
think.” Reflecting back on those years, Dr.
Pohlschröder says, “Even though things
were changing at the time, there were not
many openly LGBTQ+ scientists the in
academic space. It was very impactful for
students and the younger generation of
scientists to not only see Manuela accept
herself, but accept them too.”
While progress has been made, Dr. Tripepi
notes disparities and barriers continue to
persist for LGBTQ+ scientists. A recent
survey showed that LGBTQ+ scientists
were more likely than non-LGBTQ+
colleagues to experience harassment and
career obstacles; and research has shown
that having more visible LGBTQ+ role
models in science would make it easier
for other LGBTQ+ students to join the field.
“Visibility matters,” says Dr. Tripepi.
“I share my story with my colleagues
and students. Although I am an
underrepresented minority in science,
I am privileged compared to other
communities, and I want to help my
students receive the same kind of
opportunities I’ve had.”  KM, MM
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A Path Towards
Digital Equity
Telemedicine is a vital tool in health care, but it’s leaving some
patients behind. Jefferson researchers are on a mission to
improve ‘digital readiness’ in under-resourced communities to
bridge inequities.
BY KARUNA MEDA | ILLUSTRATIONS BY ERIN K. ROBINSON

I

t was the beginning of March 2020, and Chelsea Torres had just returned home
to Philadelphia from college for spring break. A few days into her stay, everything
changed. Whispers of a deadly pathogen had turned into full-throated cries of
caution, and the country went into lockdown. Chelsea and her parents were
alarmed when they began to feel unwell — vague symptoms that they probably would
have chalked up to a cold in any other circumstance. But amidst the novel coronavirus,
they didn’t want to take any chances, and hastened to get tested. An agonizing few days
of waiting confirmed their suspicions — they had COVID-19. Soon, they began to hear
of more cases in their tight-knit Latino community. Many of their family members and
friends had underlying health conditions and/or were essential workers and therefore at
higher risk of contracting the virus — it was the first glimpse into the disproportionate
impact COVID-19 would have on the community. Like many in the diaspora with
relatives living abroad, they also grew concerned about their family back in the
Dominican Republic.
Over the next few days and weeks, Chelsea and her parents navigated the uncertainties
of trying to get care. This meant using telemedicine, which many healthcare centers had
transitioned to. Chelsea used her smart phone and computer routinely, and had already
adjusted to online learning; using telemedicine didn’t daunt her. But her parents weren’t
as accustomed to technology, and needed her help accessing patient portals and setting
up video visits. There was something else that was holding them back that Chelsea
couldn’t quite put her finger on; it seemed like mistrust and apprehension about this
new form of medical care.
A couple of miles away at Jefferson Health, Kristin Rising, MD was noticing
something similar.
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The Digital Divide Includes
Access and ‘Readiness’
“It was all hands on deck,” recalls
Dr. Rising, an emergency medicine
physician and clinical researcher.
An onslaught of patients sickened by the
coronavirus was quickly filling up the
clinic; meanwhile those with chronic
illnesses and other health concerns still
needed care. Fortunately, Jefferson Health
had been honing its telehealth platform —
JeffConnect — since its launch in 2015, and
was poised to expand the service.
“Our call volumes tripled overnight,” says
Anna Marie Chang, MD, an emergency
medicine physician working closely with
Dr. Rising, and a core member of the
JeffConnect team. “We trained more than
a hundred doctors across the enterprise to
handle the influx.”

explains. “It was clear that many patients
just weren’t comfortable using telehealth,
and we needed to find out why.”
Dr. Rising started delving into research
published on ‘the digital divide’ in an effort
to guide solutions. She came across the
term ‘digital readiness’ — it was a concept
that encompassed the complexities
surrounding the use of technology and
addressed three main questions:
1. D
 oes a person have access to a device/
technology, and the skills or knowledge
to use it?
2. Does a person accept the technology as a
relevant tool for its designated purpose,
e.g. online learning or telemedicine?
3. D
 oes a person trust the technology?
These questions provided a framework for
understanding nuances that drive patient
behavior, like those Chelsea observed in
her parents.

Even as telemedicine sky-rocketed during
this first wave of the pandemic, there were
many patients who didn’t have
the resources to access it. A
glaring spotlight was put on the
"It's about a mind shift that we
‘digital divide’ that particularly
impacts patients of lower
healthcare providers have to
socioeconomic and educational
help people get through."
status, communities of color,
those who are older, or living
Dr. Rising
in rural areas. These were
the same communities that
“For so long we’ve thought about the
were being hit hardest by the pandemic.
digital divide mainly in terms of access
Without addressing the lack of access,
and knowledge,” says Dr. Rising. “This
telemedicine could worsen the impact of
concept of ‘readiness’ shows us that
COVID-19 and existing health disparities.
it’s more about a mind shift that we as
healthcare providers have to help people
As part of the Coronavirus Aid, Relief, and
get through.”
Economic Security (CARES) Act, Jefferson
Health received funding from the Federal
Communications Commission (FCC) (as
Bridging the Digital Divide
well as from the Philadelphia Mayor's
Fund, TD Bank, and Aetna/CVS) to expand
It was apparent that patients were on a
their telehealth-related services. Dr. Rising
spectrum of digital readiness, and the
led the application of the CARES funds
critical next step was to identify those
which were used to purchase iPads and
who were less ‘digitally ready.’ At the
remote monitoring devices to give to
Sidney Kimmel Cancer Center — Jefferson
patients who didn’t have devices at home.
Health, physicians were alarmed to realize
But she and her colleagues soon realized
that this was a significant portion of their
there was another challenge.
patient population.
“Enabling access to devices didn’t mean
patients were automatically going to make
a telehealth appointment the next day,” she
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“Cancer patients tend to be older,
and many belong to racial and ethnic
minorities, a reflection of complex health

disparities,” explains Brooke Worster, MD,
who specializes in palliative medicine for
cancer patients. “Many of these patients
were less likely to have access to or use
technology in their everyday life, let alone
in their cancer care. If we didn’t reach
out to them, they could be in danger of
not getting vital treatment, screening and
follow-up care.”
With astonishing speed, Dr. Worster and
colleagues mobilized resources and staff,
which included social workers, research
assistants, physicians and nurses, and by
late March 2020, they had created the
Telehealth Taskforce. It was designed
to provide one-on-one assistance to
cancer patients with smartphone set-up
and delivery, creation of email accounts
and online health portals, testing device
video and audio, and real-time help
during telehealth visits. Each patient had
different needs, and assistance was tailored
accordingly. Because of COVID restrictions,
all this had to be done over the phone or a
video call.
The Telehealth Taskforce
provided a model for how to
triage telehealth assistance, and
Dr. Rising saw an opportunity
to expand it to other areas of
care. She collaborated with
Rosemary Frasso, PhD from
Population Health, and others, to
create the Digital Onboarding Taskforce
in September 2020. They recruited
public health and medical students who
were eager to get hands-on patient-care
experience and offer help during a time
of crisis. They provided similar one-onone, virtual assistance as the Telehealth
Taskforce. Together, the two initiatives
helped more than 2,000 Jefferson Health
patients overcome barriers to using
telemedicine, including access, knowledge
and acceptance.

as

But, Dr. Rising says, there was one
component of ‘digital readiness’ that still
lingered— the multi-layered issue of trust.

Mistrust in Health Care
Affects ‘Digital Readiness’
Before the pandemic, Black patients
used telehealth services less often than
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"I have an opportunity
to help them feel
empowered to use
resources like
telemedicine to
take charge of
their health."
Chelsea Torres

white patients, but that gap widened
substantially as telehealth became the
primary way to see a healthcare provider.
In the early months of the pandemic, Dr.
Rising and geriatric psychiatrist Barry
Rovner, MD, led a group of researchers to
assess what could be contributing to this
disparity. They surveyed 162 Black patients
with diabetes and found that despite the
fact that over 90% of the participants had
the technology and capability to access
telehealth, only 39% had a telehealth
visit during the pandemic. They looked at
contributing factors like age, gender, years
of education, cognitive ability— and it had
nothing to with any of those. It all came
down to trust.
“Participants had less trust in doctors’
ability to diagnose and treat their
symptoms using telehealth,” explains
Dr. Rovner. “There was also the fear of
discrimination, and that doctors don’t
always have their best interests at heart.”
These fears are justified, given the long
history of abuse towards communities
of color in the U.S. medical system —
from the infamous Tuskegee Study to
Henrietta Lacks, a Black woman whose
cells were taken from her body without
her consent and widely used in medical
research. The mistrust is also rooted in
a lack of representation in the medical
field — less than 6% of doctors in America
are Hispanic, only 5% are Black, and less
than 1% are Native American. For patients
like Chelsea Torres and her parents, it’s a
struggle to find culturally competent care.
“It shows up in basic things — a doctor
might tell me to eat more vegetables
and presume I understand that to mean
leafy greens, cruciferous vegetables, etc.,”
explains Chelsea. “But, in Latino culture,
vegetables are beans, legumes, plantains,
and others that I only know the names for
in Spanish. There’s a disconnect.”
Chelsea also describes how her parents
grew up with a very different healthcare
culture in the Dominican Republic — home
remedies were a staple, like soothing teas
made from herbs in the garden; if there was
a health concern they would often call the
family doctor, or even get advice from the
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local pharmacist; medications were cheap
and didn’t require an appointment to refill.
“If you’re used to low-cost, low-effort
health care, it can be really overwhelming
to navigate the U.S. medical system,”
says Chelsea. “Then there’s the added
concern about being discriminated
against, dismissed or not understood.
And now you’re being asked to use
this new thing called telemedicine?
It’s just one more barrier. I understand
why my parents are apprehensive.”

Engaging Communities
to Build Trust
It became clear to Dr. Rising that in order
for telehealth to be truly inclusive, building
trust in under-resourced communities
would be instrumental in sustainably
leveling the playing field of ‘digital readiness.’
“But trust is not something you can build
overnight,” says Amy Leader, PhD, a key
collaborator of Dr. Rising and public health
researcher who studies health disparities.
“There are deep, systemic, generational
issues at play, and it’s going to take a lot of
work to dismantle them.”
“The taskforces reiterated a key tenet of
my research — listen to patients,” says Dr.
Rising. “This is the first step to building
trust, and it means adopting a high-touch
approach: get into the communities and
start conversations.”
Community-led organizations are a
conduit to those conversations and the
lived experience of navigating health
care. Esperanza Health Center, a multicultural ministry providing holistic health
care to the Latino and under-resourced
communities of Philadelphia, is one such
example. Esperanza has been instrumental
in providing access to culturally
competent, multi-lingual care all through
the pandemic. And their leadership
observed similar limitations in telehealth
engagement as Dr. Rising did. A natural
partnership formed in the winter of 2020,
with the eventual goal of developing
a toolkit to improve digital readiness
in Latino populations in the Greater

Philadelphia area. The toolkit would
include educational materials, in readily
understandable language and in Spanish,
to address telehealth-related barriers
specific to this community. Eventually, this
‘digital readiness’ toolkit will be replicated
in other communities; Dr. Rising hopes
to do so through an emergent telehealth
advisory board that includes partners
such as Philadelphia Fight, Philadelphia
Chinatown Development Corporation
and SEAMAAC (Southeast Asian Mutual
Assistance Association Coalition).
Together they serve refugee, immigrant,
and other under-resourced populations
across Philadelphia.
In order to understand the specific drivers
of mistrust of telehealth in the Latino
community, Dr. Rising and Esperanza
leaders are currently conducting
interviews and focus groups with
community members, led by a trusted
liaison. Chelsea Torres is one of them.
She had interned at Esperanza three
years ago, and had returned to volunteer
during the pandemic, providing education
about the vaccines and helping schedule
appointments. She heard about the project
with Jefferson Health and was chosen
to be a community research assistant.
In this role, she will collect and digest
qualitative data from her interviews with
the community, which will in turn inform
the development of the toolkit. It’s a
responsibility that she takes very seriously.
“I come from a big family, and many
of my loved ones struggle with health
conditions that maybe went neglected
because they couldn’t find culturally
competent care,” Chelsea says. “As
someone they trust, I have an opportunity
to help them feel empowered to use
resources like telemedicine to take charge
of their health.”
“It’s critical to have Chelsea on our team,
and the focus groups are a key element of
the process of building relationships with
communities that have felt disenfranchised for so long,” says Dr. Rising. “As
researchers and healthcare providers, we
need to demonstrate that we’re invested
in listening and making changes based
on what communities are telling us.”

Connecting Efforts for
Sustainable Change
Translating the lessons learned into action
is what drives the Center of Connected
Care, which launched in January 2021
with Dr. Rising at the helm. Behind her
is a multidisciplinary team, the core of
which is formed by Drs. Worster, Leader
and Chang — they bring a range of
expertise and perspectives, from social
work and population health to nursing,
cancer care and emergency medicine. One
of their foundational missions is to ensure
digital equity across all communities. This
means equitable access, comfort, trust and
flexibility of care.
“Health care is not ‘one-size-fits-all’ and
there will always be patients who prefer
in-person care to telehealth,” says Dr.
Rising. “But the idea is to give everyone
the ability to include telemedicine
in their healthcare toolbox, and the
confidence to use it when they want to.”
The partnership with Esperanza, which
is in its nascent stages, is an example
of the unique patient-centric approach

“This is the first step
to building trust, and
it means adopting a
high-touch approach:
get into the communities and start
conversations.”
Dr. Rising
the Center will take in addressing
digital readiness and their overall goal
of tackling health disparities. It reflects
a shift in the field, from research on
the community, to research with the
community, say Drs. Leader and Rising,
whose collaborative and independent
work have often included a community
or patient-advisory board. “That’s where
trust comes from, when it feels like you’re
part of the solution,” says Dr. Leader.

The Center will also expand on the
lessons learned from the taskforce; one
in particular is the need to measure the
range of digital readiness in the patient
population. Dr. Worster says that if they
had identified the least digitally ready
patients ahead of time, there would
have been a safety net for them when
the pandemic hit and forced the shift to
telemedicine. The Center hopes to provide
that by integrating a ‘digital readiness’
screening questionnaire into patient care.
The idea would be to administer it when
patients first interact with the health
system, whether through telemedicine or
during an in-person visit. It would then
be administered annually thereafter to
capture how digital readiness may change
with ever-evolving technology, says Dr.
Chang. The data collected from these
assessments will help design evidencebased and targeted interventions.
For example, if trust is the biggest barrier
for a specific patient group, then an
intervention would be centered on having
educational and information-gathering
sessions with trusted and culturally
competent liaisons. Similarly, in an
upcoming grant, Dr. Leader and Dr. Rising
propose embedding a team of speciallytrained patient navigators dedicated to
telehealth into clinical settings to guide
patients who are less comfortable with
technology.
The team has a long road ahead of them,
but Dr. Rising is excited about convincing
funders and policy makers to invest in
digital equity. A sign of their progress
already — they will host a national
conference funded by PCORI (the Patient
Centered Outcomes Research Institute)
in spring 2022, bringing together diverse
stakeholders from across the country who
have been tackling digital readiness in
their own communities to determine best
practices, understand knowledge gaps and
develop new research partnerships.
“It took a pandemic to bring telemedicine
and digital inequities into razor-sharp
focus,” says Dr. Rising. “And telemedicine
is here to stay, so it’s up to us to ensure that
it becomes a means of decreasing health
disparities, and not increasing them.” 
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JeffSolves: A New
Way of Thinking
BY RONI DENGLER | ILLUSTRATIONS BY TRACI DEBERKO

Medical and industrial design students
team up to develop medical devices to
solve healthcare challenges.
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D

esign isn’t what most aspiring doctors think about when considering
medical school. But for Emily Marshall, a second-year medical student,
design drew her in when interviewing to attend Sidney Kimmel Medical

College at Thomas Jefferson University.
Through the JeffSolves MedTech program, Jefferson offers medical students
like Marshall a rare opportunity to design
and develop a novel medical device from
the ground up.
“People who go into medicine don’t
have exposure to designing medical
devices, even though we’re using
them every day,” Marshall says. “The
JeffSolves program is a very unique
opportunity to learn about what
goes into product development in the
medical space.”
Now entering its seventh year, JeffSolves teams medical students up with
industrial design students to identify a
real-world healthcare challenge that a
medical device could solve.
The student-teams work with clinicians,
patients and experts in engineering and
design to conceptualize and develop a
medical product. The process includes
giving products a name, creating a
brand and submitting provisional
patents on the products to protect the
intellectual property.
This year, 19 students who broke into
four product-designing groups worked
on their project over the course of
six months, plus full-time over the
summer. In addition to guidance from
Industrial Design and Health Design
Lab faculty, JeffSolves partnered for its
third year with Bresslergroup, a local
design firm that specializes in medical
devices. Teams also worked with Savvy
Cooperative, an organization where
patients are compensated for their expert knowledge about their conditions.
The new partnership helped to provide
teams with patient insight and to foster
patient-centered designs.

ultimate goal of selling the intellectual
property to a medical device company
to manufacture the product. Students
from this year’s program presented
their products to a combined in-person
and virtual audience as part of DesignPhiladelphia, an annual 10-day festival
that highlights the city’s impressive
design community.
“The idea of the program is to empower
students,” says Rob Pugliese, PharmD,
director of innovation design and
co-founder and managing director of
Jefferson’s Health Design Lab, out of
which the JeffSolves program runs.

Conpono Collar
Marshall had first heard about JeffSolves
from a former participant before she
enrolled at the medical school, and the
program intrigued her. But when the
time came to come up with a project,
she and her team struggled to zero in on
a problem to address. In prior years, the
JeffSolves program started with a reverse
pitch night,” where clinicians and physicians would lay out a smorgasbord of
problems for the student teams to solve
with their products. This past year, however, identifying key health problems to
solve was up to the students. They had to

Marshall and her group, mentored by
Morgan Hutchinson, MD, director
of education for the Health Design
Lab, went to the experts. They met
with Jefferson neurologist Hristelina
Ilieva, MD, PhD, who specializes in
amyotrophic lateral sclerosis (ALS), a
progressive neurodegenerative disease
more commonly known as Lou Gehrig’s
disease. The conversation revealed
that patients with ALS and other
neuromuscular conditions wear cervical
support collars to help weakened neck
muscles support the head.

Jennifer Hegelein (left) and Emily Marshall (right)

Grip' N' Go
In talking with patients, Marshall and
her teammates realized that the current
spectrum of available cervical collars
on the market weren’t meeting patient
needs. Collars were either intense medical-grade collars intended for immobilizing the neck to prevent spinal cord injury,
or over-the-counter collars that did not
provide sufficient support. One patient
explained how difficult it is to eat with a
collar on. “That stood out to us,” Marshall
says. “The device should permit patients
to do the things they still can do at this
point in their disease, because eventually
those things are taken away from them.”
Drawing on patient input, the team
aimed to create a collar that is not only
sturdy enough to provide sufficient head
support for patients, but also flexible
enough that they can eat and do other
routine activities while wearing the
collar. To achieve this, Marshall and
her teammates designed a collar with a
pivoting jaw piece. They started by hacking apart existing collars and trying to
re-configure them to include an adjustable and movable mechanism.
But the design truly came together when
they discovered a mechanism on helmets
that welders use to protect their eyes and
faces from ultraviolet light and sparks
when heating metals. Welding helmets
have a part that rotates the helmet into
different height settings. Marshall and
her team took this mechanism out of a
welding helmet and put it into one of the
handful of prototype collars they made,
“and it works pretty well,” she says.

The program culminates in public disclosure of the student-teams’ ideas to
seek interested parties that might help
move the product forward, with the

Conpono Collar
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identify problems that they felt strongly
about and believed had market viability
within this year’s program theme: neurology, neuroscience and rehabilitation.

Throughout the design process,
the team tested their prototypes on
themselves to find out what was and
wasn’t working. The group is now
working on refining the model and

will soon move to a 3D printed version before testing with patients.
“It’s a very different way of thinking
about diseases than we do in typical
medical education,” says Marshall.
“Going forward, I want to make sure I
always ask questions about a patient’s
needs and issues with medical devices.”
Emily Marshall (medical student), Jennifer
Hegelein (industrial design graduate
student), Nia Robinson (industrial design
undergraduate student), Eshika Agarwal
(medical student)

Grip’N’Go
With a background in biomedical engineering, second-year medical student
Sara Belko found that the JeffSolves
program was a natural fit.
“I want to be that link between medicine
and engineering, because right now
there's a big gap,” she says. “Engineers are
making products that don't necessarily
solve patients’ problems, and doctors
are taking these products and actually
modifying them to be better.”
Belko and her team decided to focus
on spinal cord injury and interviewed
patients who use assistive devices like
wheelchairs, walkers and canes to find
out what issues come up for them in
their everyday lives. A topic that kept
cropping up was sanitation concerns
around using public restrooms.
To use the toilet, people who use
wheelchairs often have to grab the toilet
seat with their hands to transfer their
bodies from the chair to the toilet. The
lack of sanitation hinders people from
wanting to use public toilets. Also, toilet
seats aren’t very sturdy. People who use
wheelchairs don’t feel very stable when

transferring from their chair to the toilet.
Some have even fallen while transferring because the seat snapped. Wheelchair-accessible stalls with bars aren’t
always available or in the right position.
To design their product, the team started
by understanding what the transfer from
wheelchair to toilet seat looks like. Guided
by teammate Aaron Anderson, who uses
a wheelchair, they broke down the process
into 28 different steps. The team went
into public restrooms to observe different
versions of the environment they were
working in. Then they went a step further.
They bought and installed a toilet and set
up a mock environment so they could
practice transfers themselves and better
understand a user’s perspective.
Belko and her teammates, mentored
by Kristy Shine, MD, PhD, assistant
professor of Emergency Medicine and
director of Scholarly Inquiry at Sidney
Kimmel Medical College, went through
many iterations of concept design and
testing, 3D printing more than a dozen
prototypes. After testing on 30 toilet seats,
the team produced Grip’N Go, a portable
weight-bearing handle that attaches to the

Left to right: Blake Rivas, Aaron Anderson, Hannah Anderson,
Emily Furstenberg, Sara Belko present their device at the pitch
event at the Bresslergroup which took place on October 13, 2021.
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TremEase

Soleia

toilet to enhance stability and sanitation.
With the device, no bigger than a purse,
users no longer have to touch the toilet
seat during self-transfer. Belko and team
are now moving forward with two designs and hope to test them with patients
who use wheelchairs soon.
The project helped Belko embrace areas
of medicine and life that often feel taboo
to speak about. “No one really likes to
talk about how private toileting is,” Belko
says. “All the patients we talked to were
super appreciative that someone was
finally talking about these issues.”
Sara Belko (medical student), Aaron
Anderson (industrial design graduate
student), Emily Furstenberg (medical
student), Hannah Anderson (medical
student), Linda “Blake” Rivas (medical
student)

Soleia
Industrial design student Gigi Geary
participated in JeffSolves in 2020 with
a team that developed a flexible barrier
to minimize contamination in IV lines,
a device called Conexo. This year, Geary
and her new teammates chose to work
on cerebral palsy, a condition that
affects movement, balance and posture.
It is often the result of abnormal
brain development before birth. Many
individuals with cerebral palsy who are
able to walk do so with an altered gait.
The team, mentored by Bon Ku, MD,
assistant dean for Health and Design
and director of the Health Design
Lab, met with doctors, physical and
occupational therapists and patients to
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Left to right: Jenna Mendel, Joey Paladino,
Kayla Brockmeyer demonstrate the TremEase gloves.

learn more. Patients noted that their
shoes would wear down very quickly.
Online support groups revealed that
many patients require shoe lifts because
one leg is significantly shorter than the
other. Shoe lifts can be expensive and
often must be special-ordered from
a shoe company. Because children
grow so fast, kids with cerebral palsy
are often limited to one pair of shoes,
which doesn’t always match their attire
or the occasion.
Team Soleia’s goal is to make walking
more comfortable for pediatric patients
with leg-length discrepancies, and to
increase the longevity and adjustability
of shoe lifts. Using some of their
old shoes, the team met up over the
summer to try out different design
ideas and materials. “Sometimes it felt
like carpentry,” says Katie Bormes, a
medical student on the team. “We were
in the design lab using a band saw to
cut out shoe shapes from foam.”
To test out their design ideas, Bormes,
Geary and their teammates would
attach prototypes to their old shoes,
then walk, run and jump while wearing
them. There were multiple rounds of
tweaking the design. Bormes says the
iterative design process provided a new
way of thinking, compared to the stepby-step problem solving and diagnosis
in medical school.
To address patient concerns with
current shoe lifts, the group’s designs
are sleek, either incorporating design
elements of patients’ existing shoes,
or creating lifts in neutral colors
that blend in rather than stand out.

Left to right: Anusha Koka, Zane Gouda, Kathryn Bormes.

Ideally, the team would like the shoe
to adjust over three shoe sizes and
be interchangeable between pairs of
shoes. They’re working on refining the
attachment mechanism. Given that
their target patient population struggles
with maintaining balance, they want to
be certain that their product is highly
stable for everyday activities. Once they
are confident in the safety, the team
will send it out for user feedback to
continue to improve the design.
“It’s going to go far and help so many
people, and at the end of the day,
that’s what I want to do as a designer,”
Geary says.
Gigi Geary (industrial design graduate
student), Katie Bormes (medical student),
Jane Won (industrial design undergraduate
student), Anusha Koka (medical student),
Zane Gouda (medical student)

TremEase
Medical student Jenna Mandel and
her teammates decided to develop
a customizable weighted glove for

patients with benign essential tremor,
a neurodegenerative disorder that is
personal to Mandel. Her grandmother
has the condition. Benign essential
tremor causes involuntary, rhythmic
shaking that is often most prominent
in the hands. Movement exacerbates
the tremor. There are limited
treatment options, and, for many
patients, the available treatments
only work for a short period.
It can be an isolating disease. Patients’
hands shake when bringing food or a
drink to their mouths, which causes
spills, leading to embarrassing and
frustrating experiences for patients
that can deter them from going out in
public. Over time, tremors get worse.
When Mandel and her team joined
online support groups for people with
essential tremor, they asked members about their biggest day-to-day
problems. Then working with Savvy
Cooperative, they conducted video
interviews with patients. This intensive,
patient-centered approach revealed
a gap in currently available weighted
gloves that help to dampen tremors.
On one end of the spectrum, there
are one-size-fits-all gloves that are
cheap but do not work very well. On
the other end, there are gloves that
are tailored to an individual's specific
tremor and work much better, but are
very expensive, with poor insurance
coverage. Moreover, each individual's
tremor is unique, requiring personalized design elements in their gloves.
“We started to ask ourselves if we
could create something cost-effective
that could be tailored to each patient’s
tremor,” says Mandel.

The team put together 50 prototype
drawings and produced a handful of
physical prototypes. Using a breathable
material, the team designed anti-tremor
weighted gloves that have a Velcro-like
material on the backside, where small
weights can be attached to any part of
the glove, as more intense tremors tend
to require more weight to dampen. “We
wanted to make it as low-profile and
as comfortable as we possibly could,”
Mandel says. They are easy to put on,
pull off and wash, and moving or adding weights is simple.
Mandel and her teammates were able
to test the glove with a few patients. At
the DesignPhiladelphia event, Mandel
and her team, who were also mentored
by Dr. Ku, showed a video demonstration of a patient using the glove.
Without the glove, the individual’s
hand shook visibly while performing
an everyday work task; with the glove,
his movements were fluid and without
tremor. “It was powerful to be able to
demonstrate the benefit of the gloves
for actual patients,” says Mandel.
Jenna Mandel (medical student), Justin
Horst (industrial design graduate student),
Fletcher Viders (medical student),
Joseph Paladino (medical student), Kayla
Brockmeyer (medical student)

Future Forward
The teams from this year’s JeffSolves
MedTech Challenge program are now
refining designs and testing them on
patients in the clinic.

for Institutional Review Board (IRB)
approval, which will enable the team
to assess the utility and validity of
TremEase on patients in the clinic. In
the meantime, they continue to modify
the design based on user feedback. Ultimately, they hope to make TremEase
available as an over-the-counter product or through an online provider, such
as Amazon, as soon as possible.
Similarly, Sara Belko and her teammates are in the process of applying for
IRB approval to test out different handle designs for the Grip’N Go and to
see how patients will use it long-term.
The team has submitted a provisional
utility patent and is advertising the
device on a UK-based digital partnering
platform called IN-PART that connects
university research with industry R&D,
where they hope to match with licensing opportunities.
Marshall and her teammates are further refining a few design details before
developing a computer-assisted design
and 3D-printing the Conpono collars
to test with patients in the ALS clinic
at Jefferson, for example. Soleia is on a
similar path.
“By connecting students with clinicians
and patients, and empowering them to
work with the engineers and designers
who can give them the tools to solve
problems by creating a product, JeffSolves operates much like a start-up,”
Pugliese says. “All these devices have
promising futures.” 

Mandel and the TremEase team are
currently in the process of applying
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The

			
Heart’s
“Little Brain”
Researchers develop the first ever 3D map of the
heart’s nervous system, providing a foundation for
understanding the complexities of heart health.

BY KARUNA MEDA

O

n the computer screen, a 3D model of a heart rotates
seemingly in mid-air, a carousel of colors and contours.
Amidst the blue and purple waves that denote the heart’s

powerful muscles sit a cluster of yellow dots. To anyone else, it
looks like a meaningless blob. But to James Schwaber, PhD, and
Raj Vadigepalli, PhD, it represents a culmination of nearly three decades
of work, a long-awaited key to a world of unanswered questions.

Let’s rewind…
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"The map demonstrates that the local control
of the heart is much more nuanced than we’ve
been able to appreciate..."

Male vs. Female: A comparison of the “little brain”
in the male heart (yellow dots) and female heart
(pink dots). The distribution of the neurons is different,
and there are fewer neurons in the female heart.
Images captured by Shaina Robbins, MS

Dr. Vadigepalli

T

hirty years ago, the scientific
and medical communities were
desperately trying to find answers
for heart disease, which has been the
single biggest killer in the United States
since 1921. Attention turned to a massive
and meandering network of nerves
called the vagus nerve — it carries signals
from the brain, the master organ of our
body, to other organs, including the
heart. Scientists found that when these
signals weren’t sent properly, it could
actually impair heart health and even
lead to heart failure. When they poked
the vagus nerve with an electrode to
help jump start it, they found that an
ailing heart could actually pump better!
It was a thrilling finding. But there was a
problem: the scientists didn’t know where
the vagus nerves ended in the heart —
was it a certain chamber, or a muscle,
or an electrical node? Which of these
connections could explain how the vagus
nerve affects heart health?
Around the same time, the early 1990’s,
researchers found that the heart had
nerve cells or neurons that were akin to
the ones that made up the brain. In other
words, the heart had its very own nervous
system that could function independently
of the brain! Affectionately called “the
little brain” of the heart, it became a point
of fascination in the field — why does
the heart need its own nervous system
anyway? How does it help the heart
function? It also became a potential target
for the vagus nerve. Could a connection
between the brain and the “little brain” be
the key to restoring heart health?
Drs. Schwaber and Vadigepalli have been
at the forefront of trying to answer these
questions for the last 25 years, giving
critical insight into the heart’s nervous
system. In the last five years, serendipity
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brought them together with like-minded
experts and advanced technology that
allowed a major breakthrough: the firstever 3D map of the heart’s “little brain.” It
is a map that gives an unprecedented look
at not only how the neurons are organized
in the heart — that undiscerning blob of
yellow dots — but also their biological
properties. For the first time, our researchers
are able to appreciate the spatial and
functional relevance of the heart’s neurons
in keeping the organ healthy, giving us new
clues about how to tackle the longstanding
issue of heart disease.

Tracing the Connections
between the Heart and
the Brain
The connection between the heart and
the brain goes back to 1884, when the
psychologist William James famously
described this scenario : “Imagine you
are walking through the woods, and you
come across a grizzly bear. Your heart
begins to race. You feel afraid, and you
run.” The concept suggests that the physical reaction (a racing heart) drives the
emotional experience (fear). This interplay
has always fascinated Dr. Schwaber.
In the early 1990’s, he was at the DuPont
Company in Wilmington, Delaware, and
was particularly interested in the burning
question at the time — how does the vagus
nerve connect to the heart?
By then, researchers discovered that the
vagus nerve connected to the sinoatrial
node, which controls heart rate. “That connection made sense for heart health,” says
Dr. Schwaber. “But I wanted to know if
the vagus nerve connects to the ventricles,
the chambers that pump blood to the rest
of the body. A connection here could be
beneficial too.”

To shed light on this, Dr. Schwaber turned
to a molecular biologist at DuPont by
the name of Lynn Enquist, PhD, who
was developing a novel technique using
a modified virus to label multiple relay
points in a neural pathway. When Drs.
Schwaber and Enquist injected the virus
into the ventricles of the rat heart, they
traced the connections all the way back
to the neurons in the brain that gave rise
to the vagus nerve. They had just shown
that the vagus nerve does indeed connect
directly to the ventricles!
It was a major finding that challenged the
accepted view on how the vagus nerve
might affect the heart. But there was pushback — some believed that the observation
was simply an artifact of the new tracing
technique. The field needed convincing with
more conventional methods.
Dr. Schwaber had help from a former
lab member — Frank Doyle, PhD — who
had just started his first faculty position in chemical engineering at Purdue
University and recruited a postdoctoral
researcher, Zixi Cheng, PhD. They were
able to validate the earlier findings, but
their tracing revealed something else — as
nerve fibers left the heart to go the brain,
some looped back into the heart. In fact,
they were going back to the heart’s “little
brain,” which had just been described in
1991 by a scientist named Dr. J. Andrew
Armour. It was still poorly understood,
and the researchers were unsure what to
make of this internal loop. This is where
Dr. Vadigepalli entered the scene.

The Heart’s “Little Brain”
through the Eyes of an Engineer
Dr. Vadigepalli was pursuing his PhD in
systems engineering at Purdue University
in Dr. Doyle’s lab when he was pitched
this idea of a new circuit between the
brain and the heart.
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"We’ve created a foundation for developing 3D
maps for other organs in animal models and
ultimately in humans, in health and disease.

The possibilities are endless."
Whole heart stained
for neurons

Knife-edge scanning
microscopy

Image stack assembly
~2,000 sections per heart

Dr. Schwaber

Annotate and mark thousands
of neurons

How to build a 3D heart: The fully digitized, single-cell resolution images were painstakingly made by slicing a heart stained for neurons, and then mapping those labeled-image
sections onto a computational scaffold.

A SPARC of Serendipity

"…the heart’s ‘little brain’ resembled
an internal loop that engineers call local
controllers — so what is this one adding
to the control of the heart?"
Dr. Vadigepalli

“The last time I took a biology class was in
high school,” says Dr. Vadigepalli. “I didn’t
know anything about all the controversy
that surrounded this new anatomy – but it
was fascinating to me from an engineering perspective.”
The heart reminded Dr. Vadigepalli of a
control system, a bread-and-butter concept
of engineering. Control systems are all
around us – think about the cruise control
in your car that maintains a safe speed,
or the thermostat that works to keep your
home at a preferred temperature. These
systems work in such a way that when
you change the information input, they
can adjust to achieve the desired outcome.
“The heart receives input from the brain
about our internal state and environment,
and it adjusts to maintains outputs like
heart rate, blood pressure, etc. accordingly,” explains Dr. Vadigepalli. “But the nerve
fibers that were found going back into the
heart’s ‘little brain’ resembled an internal
loop that engineers call local controllers –
so what is this one adding to the control
of the heart?”

This became the basis of Dr. Vadigepalli’s
thesis work, from the mid to late 1990’s.
Through mathematical modeling, he found
that when the internal loop was on, it
could fine tune how the heart responds
to signals from the brain. This improved
the heart’s performance and made outputs
like heart rate more reliable. When it was
off, the heart’s “little brain” couldn’t correct
local disturbances, and the external loop
to the brain had to be recruited instead,
making the control system less efficient.
Without the internal loop playing this
role of damage control, the heart could
become erratic, leading to an irregular
heartbeat or arrhythmia – or so the modeling predicted.
This work finally shed some light on the
function of the heart’s “little brain” and
provided evidence for it to be an ideal
target for the vagus nerve. It also gave rise
to new opportunities for integrating systems engineering into the field. But these
mathematical models were hypothetical,
and needed to be proven with experimental work. Many questions remained.
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In 2000, Dr. Schwaber and Dr. Vadigepalli
brought their respective expertise to
Jefferson, joining forces in the new Daniel
Baugh Institute for functional genomics and
computational biology, which Dr. Schwaber led.
For the next decade, they switched focus
from the heart to the brain, studying the
“central controller.” Scientists had developed maps of the brain in different animal
models that could pinpoint the position
of individual neurons and the genes they
expressed. These maps gave insight into
how neurons could be spatially organized
in intricate circuits, and how their genetic
identity determines their function in
these circuits. It was exactly the kind of
map they needed for the heart, says Dr.
Vadigepalli, to help them understand the
function of the “little brain.” But such a
map did not exist yet.
In 2015, their luck began to change
when a NIH funding program called
‘Stimulating Peripheral Activity to Relieve
Conditions’ or SPARC was conceived.
It brought together researchers who
studied different organ systems and
their communication with the brain, a
concept called interoception. The interplay
regulates vital bodily functions like
digestion and breathing, but can also
influence our mood and cognition. Much
of the field of interoception has focused
on the vagus nerve, which in addition to
heart health, can affect the health of the
liver, the gut, the lungs, etc. The ultimate
goal of SPARC is to develop therapeutic
devices that can change electrical

activity in nerves, like the vagus, to treat
conditions like heart failure, inflammatory
disorders, diabetes, and more.
“SPARC filled this massive void in the
field and reignited our interest in the ‘little
brain’,” says Dr. Schwaber. “But there was
so much more we needed to understand
about its anatomy and function.”
As they revisited their old stomping
grounds in the heart, serendipity struck
again. They came across two new
technologies — one, an automated imaging
technique that could precisely reconstruct
any tissue in 3D; the second, a software
that could build manipulable images and
videos of these 3D reconstructions. Both
companies were shopping for customers.
It was a match made in scientific heaven.
Drs. Schwaber and Vadigepalli recruited
a core team of trainees between their two
labs — Sirisha Achanta, lab manager at the
Institute, Alison Moss, a graduate student,
Jonathan Gorky, a MD/PhD student,
Shaina Robbins, a research assistant — and
went about building a methodological
protocol from scratch. They brought their
old colleague, Dr. Cheng, now at the
University of Central Florida, back into
the fold as well, along with his graduate
student Clara Leung.
By 2019 the team had created a dual
approach pipeline — one using the
imaging technologies to build a precise
3D reconstruction of the entire rat heart
viewable via computer screen; and the
other using a technique called laser
capture microdissection to sample single
neurons for gene expression analysis.
This allowed them, for the first time ever,
to build a 3D map of the heart’s “little
brain” in the rat — one that showed the

individual positions of the neurons within
the heart’s anatomy, as well as their
genetic properties.

A Map to Endless Possibilities
As the researchers behold the floating
3D heart on the computer screen, each
turn illuminates new questions about
the cluster of yellow dots that represent
the “little brain” — how are the neurons
organized around key structures of the
heart? Can this influence how hard
and fast the heart pumps? How do the
neurons communicate with each other,
and with signals from the brain? Does
this organization and communication
change in heart disease? Given that
heart physiology differs between males
and females, does the “little brain” differ
between sexes?
The 3D map has revealed some of these
answers, amidst hitherto unknown
complexity of the heart’s “little brain.”
The researchers found that the neurons
in the rat heart are clustered around
the sinoatrial node, positioning them
optimally to monitor and regulate
heartbeat. The map also allowed them
to pinpoint how the “little brain” is
organized and wired differently in male
vs. female rats; for instance, although they
found fewer neurons in the female heart
compared to males, it doesn’t impact the
heart’s essential functions. This provides
clues as to why there may be differences
in cardiovascular disease between men
and women.
The team also explored the “little brain” in
the pig heart, which is more anatomically
comparable to the human heart. They
found that unlike neurons of the brain,

which are often defined by the chemical
they release — either ones that augment or
depress activity, etc. — neurons of the heart
had much more fluid expression of these
chemicals. It was as if the heart’s neurons
contained multiple identities. The various
permutations and combinations allow the
neurons in the “little brain” to fine tune how
the heart responds to signals from the brain.
This validates Dr. Vadigepalli’s thesis work,
which demonstrated this fine-tuning in
mathematical models.
“The map demonstrates that the local control
of the heart is much more nuanced than
we’ve been able to appreciate,” says Dr.
Vadigepalli. “It suggests that a single drug
that turns heartbeats up or down, may not
be as effective as one that hits the right
combination of targets. There is much more
to explore in developing new therapies for
heart disease.”
The researchers are currently using the
map to understand how the vagus nerve
connects to the neurons of the “little brain”
and provide highly anticipated evidence for
how the vagus affects heart health. They
hope their findings, and work from their
SPARC colleagues, will also provide the
physiological underpinnings for how mental
states (e.g. stress), and interventions that
alter them (e.g. meditation), affect the whole
body.
“We’ve created a foundation for developing 3D
maps for other organs in animal models and,
ultimately, in humans, in health and disease,”
says Dr. Schwaber. “These maps are the key to
the brain-body connection. The possibilities
are endless.” 
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Like You’ve Never Seen Before
New methods to ‘see’ unstudied types of RNA reveal an incredibly
abundant regulatory molecule that plays a role in disease and health alike.
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BY EDYTA ZIELINSKA | ILLUSTRATION BY MONIKA JASNAUSKAITE

he human genome project, a race
to map out the code of human life,
was supposed to uncover untold secrets of
human health and disease. But even before
the 15-year project was finished, researchers
began to realize that there was much more
to understanding life than the string of
genes that coded for proteins. How did the
cell decide how much of each gene to
produce, and when? It became clear that
knowing when to turn specific genes on or
off could mean the difference between
health and diseases like cancer, Alzheimer’s
and many others.

New RNA Toolkit
cP-RNA Seq
cP-RNA-type
decoding

YAMAT Seq
Rapid tRNA
decoding

4-Leaf Clover PCR
Rapid tRNA
counting

Dumbell PCR
Rapid counting of
RNA variants

In the 1990s, researchers discovered
microRNAs, very short sequences (about 22
nucleotides) that came from the region of
DNA in between protein-coding genes.
These tiny molecules, researchers soon
found, were master regulators, fine-tuning
the cell’s genetic production. The work
opened a new field looking at the cell’s
RNA-regulators, all sped by a tool called
RNA-seq that could rapidly detect and
decode these novel microRNAs.
That tool, however, was limited to detecting
RNA types with a specific, but common,
sequence on their tails. In the past few
years, Yohei Kirino, PhD, and colleagues
developed a new set of tools and modified
old ones in order to detect the previously
un-seeable world of small RNAs. These
tools have revealed the properties of these
RNAs, where they come from and how
they may regulate health and disease.
A number of these new RNA molecules are
fragments of other well-known RNA
species, such as ribosomal RNA, messenger
RNA and transfer RNA, and contain a cyclic
phosphate (cP) tag at their end — a different
“tail” than microRNAs. Researchers had
known of these fragments, but assumed
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they were simply junk — chopped up pieces
meant for the cell’s recycler.
In 2015 and ‘16, Dr. Kirino’s lab published the
method to detect these cP-containing RNAs
(cP-RNAs). It was simple enough: add a
processing step to remove the cP tag from
cP-RNAs, before running the usual
RNA-seq. With this tool that they called
cP-RNA-seq, the researchers began to see just
how active these molecules really were.
The cP-RNAs, they showed, were involved in
hormone-dependent cancers like breast and
prostate cancers. Derived from transfer
RNAs (tRNAs), which normally deliver
building blocks to a growing protein chain,
these cP-RNAs were plentiful, especially in
hormone-driven cancers, and appeared to
promote cell replication, a key driver of
cancer growth.
Dr. Kirino and colleagues went on to find
other types of cP-RNA involved in unrelated
diseases, from neurodegeneration to
infection. During infection with
tuberculosis, for example, the researchers
found cP-RNA present at 1,000 times the
concentration as in healthy individuals.
What’s more, these cP-RNAs appeared to
act as a cytokine, spreading the alarm for
inflammation and immune activation.
Unlike cytokines, which are a chemical
signal, the cP-RNA would jump across
membranes within an exosome bubble
released from one cell and absorbed by
another. Once inside, they activate a
toll-like receptor,TLR-7, that detects and
responds to RNA molecules and activates
immune cells.
Most recently, the group discovered that
cP-RNAs were involved in helping maintain
genome integrity in sperm and egg cells.
They showed that cP-RNAs are the precur-

mRNA

+

transposon
RNA

2

cP

cP

cP

cP

sors to piRNA, a familiar and essential
molecule that silences jumping genes —
transposable elements — in these germline
cells. This silencing prevents jumping genes
from introducing mutations that can cause
harm or even kill the cell.

cP

“The Computational Medicine Center is
developing methods, computational and
experimental, for identifying different
classes of RNA and determining their
function. Dr. Kirino’s work uncovered an
intriguing class of RNA that had remained
‘invisible’ to standard sequencing approaches,” says Isidore Rigoutsos, PhD,
Richard W. Hevner Professor and Director
of the Computational Medicine Center.

piRNA
cP

3

TLR7

cP

The Kirino group developed other tools to
see the unseen RNA world. They created
the YAMAT-seq, an efficient method for
sequencing tRNA, and the four-leaf clover
qRT-PCR to quantify these twisted
molecules; and the Dumbbell-PCR, a
method to quantify specific variants of
microRNA and other small RNAs.

TLR7
cP

cP

cP
cP

RNA Fragments in Health and Disease

cP

Messenger RNA (mRNA) are transcribed from DNA in
the nucleus and captured by ribosomes sitting on the
surface of the endoplasmic reticulum. Ribosomes read
the mRNA messages and attract transfer RNA (tRNA)
to build the protein components of life(1). But there are
many other types of RNA that are then converted into
RNA fragments called cP RNA. With the help of a new
tool called cP-RNA-seq and others, researchers can see
what these cP-RNA fragments are doing in the cell (2).
For example, these small RNA fragments are processed
further to become piRNA, which silence the jumping
genes that cause instability in sperm and egg cells (3);
they transfer between immune cells to activate immune
reactions to infectious disease (4); and their numbers
spike in hormone-dependent tumors like breast and
prostate cancer (5), possibly spurring aggressive disease.
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